Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
---|
04/01/2009 | CN101397288A Method for preparing 2,2-dialkyl-5-hydroxymethyl-1,3-dioxanes compounds |
03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
03/31/2009 | CA2356121C Novel propargylether derivatives |
03/26/2009 | US20090082395 Soluble epoxide hydrolase inhibitors |
03/24/2009 | US7507840 Nonlinear optically active compounds that include a pi-donor conjugated to a pi-acceptor through a pi-electron conjugated bridge |
03/24/2009 | US7507764 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
03/24/2009 | US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity |
03/19/2009 | WO2009035951A2 Soluble epoxide hydrolase inhibitors |
03/19/2009 | WO2008139467A3 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses |
03/19/2009 | US20090076062 Organic Compounds |
03/18/2009 | EP2036547A2 Treatment for Attention-Deficit Hyperactivity Disorder |
03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
03/18/2009 | CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
03/18/2009 | CN101386580A Aminopropancdiols derivates, preparation method thereof and medicament composition and use thereof |
03/18/2009 | CN100469761C Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
03/17/2009 | US7504524 comprising the oxidation of the ketone function of a cyclic compound |
03/17/2009 | US7504395 Treatment for attention-deficit hyperactivity disorder |
03/12/2009 | WO2009031437A1 Tetra- or penta-cyclic liquid crystalline compound having lateral fluorine, liquid crystal composition, and liquid crystal display element |
03/12/2009 | WO2009030396A1 Method for the production of lactic acid dilactide or polyesters producible thereof |
03/12/2009 | WO2009030330A1 Condensation and washing device, polymerisation device and method for cleaning process steam during the production of polylactide |
03/12/2009 | WO2008145941A3 Coproduction of cyclic carbonates and of nitriles and/or of fatty amines |
03/12/2009 | US20090069579 Process and compound |
03/12/2009 | US20090066905 Componds for use in liquid crystal devices |
03/12/2009 | US20090065739 Liquid crystal compound having chloronaphthalene moiety, liquid crystal composition, and optical device |
03/11/2009 | EP1835902B1 Spiro[bornyl-2,4'-(1,3-dioxanes)] and their uses as fragrance ingredients |
03/11/2009 | CN101381361A Organic compound for recording layer and optical recording medium including the same |
03/11/2009 | CN100467459C 1,4-benzodioxane sulfonic acid compound and use thereof as electron-acceptor material |
03/11/2009 | CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives |
03/11/2009 | CN100467436C Process for preparing alkoxy- and aryloxy-phenols |
03/05/2009 | WO2008088487A3 Phosphorus-sulfur fr additives and polymer systems containing same |
03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
03/05/2009 | US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives |
03/05/2009 | US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same |
03/05/2009 | DE102007041854A1 Bifunktionelle DHA-Derivate Bifunctional DHA derivatives |
03/04/2009 | EP2031083A1 Method for manufacturing lactic acid dilactid or polyesters from lactic acid |
03/04/2009 | EP2030667A1 Condensation and washing device, polymerisation device and cleaning of process vapour in polylactide production |
03/03/2009 | US7498460 Isophthalic acid derivatives |
03/03/2009 | US7498394 (2-Methyl)-acrylic acid 2-benzyloxycarbonyloxy-ethyl ester; higherpolymerization rates and that polymerize more completely than conventional monomers with multiple vinyl functionalities; curing efficiency, allows optimum polymer properties to be achieved with minimized irradiation times and intensities |
03/03/2009 | US7498292 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
02/26/2009 | WO2009024492A1 Leukotriene b4 inhibitors |
02/26/2009 | CA2696967A1 Leukotriene b4 inhibitors |
02/25/2009 | EP2027087A2 Intracellular kinase inhibitors |
02/25/2009 | CN101372483A Method for synthesizing substituted benzo (1,4) dioxane derivative |
02/19/2009 | WO2009022311A2 1,2-diamido-ethylene derivatives as orexin antagonists |
02/19/2009 | CA2694993A1 1,2-diamido-ethylene derivatives |
02/18/2009 | CN101367789A Method for preparing 1,4-diethyleno dioxide ketone |
02/17/2009 | CA2320756C Process for the production of optically enriched (r)- or (s)-albuterol |
02/12/2009 | WO2009019561A2 Process for preparing chiral compounds |
02/12/2009 | US20090043115 Process for Producing Simvastatin |
02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
02/12/2009 | US20090042973 Inhibitors of aspartyl protease |
02/12/2009 | CA2695357A1 Process for preparing chiral compounds |
02/05/2009 | WO2009017261A1 Method for manufacturing ultrafine p dioxanone |
02/05/2009 | WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
02/05/2009 | US20090036691 Analogs of dicodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof |
02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
01/29/2009 | WO2008145941A9 Coproduction of cyclic carbonates and of nitriles and/or of fatty amines |
01/29/2009 | US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor |
01/29/2009 | US20090029903 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors |
01/28/2009 | EP2018361A1 Halogenated cyclic lactones and polymers made therefrom |
01/27/2009 | US7482044 dielectrically positive liquid crystalline media comprising a dielectrically positive component, component A, comprising a dielectrically positive compound of formula I, and optionally a second dielectrically positive component, component B, comprising one or more dielectrically positive compounds |
01/22/2009 | WO2009010527A1 Process for preparing cyclic glycerol acetals or cyclic glycerol ketals or mixtures thereof |
01/21/2009 | CN100453539C 5-methylene-1,3,-dioxolane-4-one inducer, doubling body, chemical amplification type anti-corrosion composition and forming method |
01/20/2009 | CA2220759C 1,4-benzodioxin derivatives |
01/15/2009 | WO2008125342A3 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
01/15/2009 | US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use |
01/15/2009 | US20090018116 Therapeutic Compounds |
01/14/2009 | CN100451014C Process for making chiral 1,4-disubstituted piperazines |
01/13/2009 | US7476690 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
01/08/2009 | WO2009004990A1 Fp receptor agonist |
01/08/2009 | US20090012319 Process for the preparation 2-substituted-derivatives of estrone and estradiol |
01/08/2009 | US20090012069 Novel Antidiabetic Compounds |
01/08/2009 | US20090009061 Composition for Conductive Materials Comprising Crosslinkable Arylamine Compounds and Use Thereof in Electronic Devices and Electronic Equipment |
01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
01/07/2009 | CN100448880C 2'oxo-voruscharin and derivatives thereof |
12/31/2008 | CN100447088C Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
12/30/2008 | US7470798 7,8-bicycloalkyl-chroman derivatives |
12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
12/25/2008 | US20080318958 New utilities of tricyclic compounds |
12/25/2008 | US20080318779 Fungicidal Composition Containing Acid Amide Derivative |
12/24/2008 | WO2008155818A1 Preventive or therapeutic agent for frequent urination and urinary incontinence |
12/24/2008 | CN101331114A 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors |
12/24/2008 | CN101330831A Bactericidal composition comprising carboxylic acid amide derivative |
12/23/2008 | US7468462 Modulate activity of Nuclear Retinoid receptors; regulating cell differentiation and cell cycle processes and cellular signaling processes regulated by thyroid hormone, vitamin D, all-trans retinoic acid; 2-[6-(3-Adamantan-1-yl-4-methoxyphenyl)-naphthalen-2-yl]-3-hydroxy-cyclopent-2-enone |
12/23/2008 | US7468393 Diarylsulfones as 5-HT2A antagonists |
12/18/2008 | US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
12/18/2008 | US20080311113 Method for treating adamts-5-associated disease |
12/17/2008 | CN101326154A Intermediate compounds for the preparation of statins |
12/17/2008 | CN100443480C Tricyclic compound and its preparation and use |
12/16/2008 | US7465733 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders |
12/16/2008 | US7465415 Reaction product of a ring-opening cyclic ester or carbonate and a photochromic initiator, especially a naphtho[1,2-b]quinone with one or more hydroxy groups, e.g., (1) 3,3-di(4-methoxyphenyl)-6,7-dimethoxy-13-methyl-13-(2-(2-hydroxyethoxy)ethoxy)-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran. |
12/11/2008 | WO2008150486A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
12/11/2008 | WO2008148853A1 N-phenyl hydrazides as modulators of the ghrelin receptor |
12/11/2008 | US20080306231 Novel perfluoroalkyl vinyl ether compound, process for preparing copolymer by using the compound, and optical plastic materials comprising copolymer prepared by the process |
12/11/2008 | US20080306013 Illudin analogs useful as antitumor agents |
12/10/2008 | CN101321789A Process for producing trioxane and at least one comonomer |
12/10/2008 | CN100441575C Process for preparation of cyclid esters and method for purification of the same |
12/10/2008 | CN100441574C Tricyclic compounds, their production and use |